Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal drops for sedation during lumbar puncture in children
ChiCTR2400090399Phase 4Not yet recruiting
- Sponsor
- Zhejiang Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in procedural pain (2 arms), sponsored by Zhejiang Hospital. Primary endpoint: Observer's Assessment of Alertness/Sedation (OAA/S) score. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2400090399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090399.